These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Addiction and the brain antireward system. Koob GF; Le Moal M Annu Rev Psychol; 2008; 59():29-53. PubMed ID: 18154498 [TBL] [Abstract][Full Text] [Related]
26. Compulsivity in obsessive-compulsive disorder and addictions. Figee M; Pattij T; Willuhn I; Luigjes J; van den Brink W; Goudriaan A; Potenza MN; Robbins TW; Denys D Eur Neuropsychopharmacol; 2016 May; 26(5):856-68. PubMed ID: 26774279 [TBL] [Abstract][Full Text] [Related]
27. A role for brain stress systems in addiction. Koob GF Neuron; 2008 Jul; 59(1):11-34. PubMed ID: 18614026 [TBL] [Abstract][Full Text] [Related]
28. Corticotropin-releasing factor within the central nucleus of the amygdala and the nucleus accumbens shell mediates the negative affective state of nicotine withdrawal in rats. Marcinkiewcz CA; Prado MM; Isaac SK; Marshall A; Rylkova D; Bruijnzeel AW Neuropsychopharmacology; 2009 Jun; 34(7):1743-52. PubMed ID: 19145226 [TBL] [Abstract][Full Text] [Related]
29. Addiction and the brain: the neurobiology of compulsion and its persistence. Hyman SE; Malenka RC Nat Rev Neurosci; 2001 Oct; 2(10):695-703. PubMed ID: 11584307 [TBL] [Abstract][Full Text] [Related]
31. The affective dimension of pain as a risk factor for drug and alcohol addiction. LeBlanc DM; McGinn MA; Itoga CA; Edwards S Alcohol; 2015 Dec; 49(8):803-9. PubMed ID: 26008713 [TBL] [Abstract][Full Text] [Related]
32. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention. Logrip ML; Koob GF; Zorrilla EP CNS Drugs; 2011 Apr; 25(4):271-87. PubMed ID: 21425881 [TBL] [Abstract][Full Text] [Related]
33. Individual differences in the neuropsychopathology of addiction. George O; Koob GF Dialogues Clin Neurosci; 2017 Sep; 19(3):217-229. PubMed ID: 29302219 [TBL] [Abstract][Full Text] [Related]
34. Noradrenergic transmission in the extended amygdala: role in increased drug-seeking and relapse during protracted drug abstinence. Smith RJ; Aston-Jones G Brain Struct Funct; 2008 Sep; 213(1-2):43-61. PubMed ID: 18651175 [TBL] [Abstract][Full Text] [Related]
36. Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Koob GF; Zorrilla EP Curr Opin Investig Drugs; 2010 Jan; 11(1):63-71. PubMed ID: 20047160 [TBL] [Abstract][Full Text] [Related]
37. CRF system recruitment mediates dark side of compulsive eating. Cottone P; Sabino V; Roberto M; Bajo M; Pockros L; Frihauf JB; Fekete EM; Steardo L; Rice KC; Grigoriadis DE; Conti B; Koob GF; Zorrilla EP Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20016-20. PubMed ID: 19901333 [TBL] [Abstract][Full Text] [Related]
38. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Koob G; Kreek MJ Am J Psychiatry; 2007 Aug; 164(8):1149-59. PubMed ID: 17671276 [TBL] [Abstract][Full Text] [Related]
39. The psychology and neurobiology of addiction: an incentive-sensitization view. Robinson TE; Berridge KC Addiction; 2000 Aug; 95 Suppl 2():S91-117. PubMed ID: 11002906 [TBL] [Abstract][Full Text] [Related]